drugset / Trial / NCT05262465
Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML
NaSingle-groupOpen-labelTreatment
Summary
Patients enrolled from each center according to confirmed criteria specified in cooperative scheme are recieved induction and consolidation chemotherapy with microtransplantation . Observe the remission rate and 2-year disease-free survival (DFS) and overall survival(OS) rate.
Timeline
- Start
- 2020-07-01
- Primary completion
- 2023-07-01
- Completion
- 2025-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | 50 mg/m2 | — |
| Subject | Azacitidine | Other / unclassified | 75 mg/m2 | — |
| Subject | Venetoclax | Small molecule | 400 mg | — |